CAH
$246.45-2.02%
as of close, Oct 27, 2026
☾ AH $246.45 -2.02%
CAH — Cardinal Health Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
60.080.0100.0120.0140.0160.0180.0200.0220.0240.0020.0M40.0M$246.45—20162019202120242026
2026-10-27
Price$246.45
MA20$229.19
MA50$208.27
Vol6.4M
Key stats#
Price data
- Price
- $246.45
- YTD price return
- +19.93%
- YTD total return
- +21.06%
- Next earnings
- Nov 5, 2026 · Before open
- Market cap
- 57.3B
- Enterprise value
- 62.8B
- Shares outstanding
- 232.6M
- 52W low
- $161.36
- 52W high
- $259.21
- From 52W high
- -4.92%
- From 52W low
- +52.73%
- 52W range
- 87%
- Beta
- 0.50
Volume
- Rel volume
- 0.85×
- 30D volume
- 1.9M
- 30D $ vol
- 437.8M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$59.6M
- Insider net 1Y
- −$61.6M
Form 4 transactions by trade date, as filed; latest on file 2026-08-19.
Fundamentals
- Sales (ttm)
- 254.2B
- Sales/share
- $1,093.18
- EPS (ttm)
- $7.23
- FCF (ttm)
- 4.5B
- FCF/share
- $19.46
- Book value/share
- -$12.40
- Net margin
- 0.67%
- ROA
- 2.99%
- Current ratio
- 0.88
Growth (CAGR, ttm) · 10Y
- Sales
- +14.24%+7.44%+9.37%+7.66%
- Net income
- +9.81%+73.16%+22.92%+1.85%
- FCF
- +144.74%+24.17%+17.40%+6.09%
- Shares
- -2.61%-2.47%-4.35%-3.10%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +12.10%+79.00%+28.30%+5.29%
- Sales/share
- +17.30%+10.16%+14.34%+11.10%
- FCF/share
- +151.29%+27.32%+22.74%+9.48%
- Dividend/share
- +0.99%+1.00%+1.01%+2.79%
- Price
- +50.50%+39.18%+39.04%+12.72%
- Total return
- +51.92%+41.18%+41.89%+15.86%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 34.1×
- P/OI (ttm)
- 21.9×
- Fwd P/E
- 17.8×
- P/S (ttm)
- 0.2×
- P/B (mrq)
- -19.9×
- P/FCF (ttm)
- 12.7×
- EV/EBITDA (fy)
- 17.6×
- EV/Sales (ttm)
- 0.2×
- FCF yield (ttm)
- 7.89%
- Dividend yield (fwd)
- 0.84%
- Dividend yield (ttm)
- 0.83%
- Dividend/share (fwd)
- $2.06
- Buyback yield (realized, 1y)
- 2.61%
- Shareholder yield (realized, 1y)
- 3.83%
- Buyback yield (cash, ttm)
- 2.37%
- Shareholder yield (cash, ttm)
- 3.23%
Vs own 10Y history
- P/E
- 76th
- P/OI
- 64th
- P/S
- 100th
- P/B
- 95th
- P/FCF
- 77th
Bar = where today’s multiple sits in CAH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-2.02%
5D
-4.31%
1M
+11.91%
3M
+7.46%
YTD
+19.93%
1Y
+50.46%
5Y
+419.50%
Recent filings#
- Oct 18-K · Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
- Aug 19Insider sale · Hollar Jason M. (Chief Executive Officer) sold 124,529 shares for $29.4M on 2 days since Aug 18
- Aug 19Insider sale · Scherer Mary C. (Chief Accounting Officer) sold 2,302 shares for $546K at $237.39–$237.40
- Aug 18Insider sale · Alt Aaron E (Chief Financial Officer) sold 42,000 shares for $9.9M at $234.55–$237.26
- Aug 18Insider sale · Mason Stephen M (CEO, GMPD Segment) sold 35,000 shares for $8.3M at $234.59–$237.26
Financial statements
Open full CAH financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
